CLINICAL_TRIALS withdrawal · 2012-02-22

Clinical Trial Update: Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer [Phase 2]

A Phase 2 trial evaluating chemotherapy for unresectable primary or metastatic kidney cancer has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: M.D. Anderson Cancer Center | Conditions: Liver Cancer, Metastatic Cancer | Phase 2 | Status: WITHDRAWN